# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA284464 | 1 | Activity | 0 | ALA1743308 | Substrate | Homo sapiens | |||||
2. | ALA284464 | 1 | Activity | 0 | ALA1743307 | Substrate | Homo sapiens | |||||
3. | ALA284464 | 1 | Activity | 0 | ALA1743315 | Substrate | Homo sapiens | |||||
4. | ALA284464 | 1 | Activity | 0 | ALA2077093 | inducer [+] | Rattus norvegicus | |||||
5. | ALA284464 | 1 | Activity | = | 2 | pm/min/mg | ALA1908093 | pm/min/mg | Homo sapiens | |||
6. | ALA284464 | 1 | Activity | = | 7 | pm/min/mg | ALA1908085 | pm/min/mg | Homo sapiens | |||
7. | ALA284464 | 1 | Activity | = | 1 | pm/min/mg | ALA1908083 | pm/min/mg | Homo sapiens | |||
8. | ALA284464 | 1 | Activity | = | 20 | pm/min/mg | ALA1908087 | pm/min/mg | Homo sapiens | |||
9. | ALA284464 | 1 | Transacetylation rate | = | 19.3 | nM/mg*min | ALA747006 | nM/mg*min | ||||
10. | ALA284464 | 1 | Adduct formation | = | 22.8 | ALA636967 | ||||||
11. | ALA284464 | 1 | Transacylation rate | = | 73.2 | ALA636968 | ||||||
12. | ALA284464 | 1 | Activity | 0 | ALA771347 | carcinogenic activity | Rattus norvegicus | |||||
13. | ALA284464 | 1 | Activity | 0 | ALA770573 | carcinogenic activity | Rattus norvegicus | |||||
14. | ALA284464 | 1 | Activity | 0 | ALA769713 | carcinogenic activity | Rattus norvegicus | |||||
15. | ALA284464 | 1 | Activity | 0 | ALA771336 | carcinogenic activity | Rattus norvegicus | |||||
16. | ALA284464 | 1 | Activity | 0 | ALA771448 | carcinogenic activity | Rattus norvegicus | |||||
17. | ALA284464 | 1 | Activity | 0 | ALA770584 | carcinogenic activity | Rattus norvegicus | |||||
18. | ALA284464 | 1 | Log rate | = | 0.87 | ALA637893 | ||||||
19. | ALA284464 | 1 | Rate | = | 7.5 | nM | ALA631781 | nM | Cricetinae | |||
20. | ALA284464 | 1 | Ratio | = | 360.4 | M-1 s-1 | ALA845375 | M-1 s-1 |